Nasturtium, Indian Cress Cancer Research Results

Nast, Nasturtium, Indian Cress: Click to Expand ⟱
Features:

Nasturtium (Tropaeolum majus) — Edible medicinal plant and functional food characterized by high concentrations of the benzyl glucosinolate glucotropaeolin. When plant tissue is disrupted, endogenous myrosinase hydrolyzes glucotropaeolin to benzyl isothiocyanate (BITC), a bioactive isothiocyanate with antimicrobial, anti-inflammatory, metabolic, and anticancer activity.

Product class: Food Source / medicinal herb / glucosinolate-rich plant.

Major bioactive compounds: Glucotropaeolin (benzyl glucosinolate), benzyl isothiocyanate (BITC), polyphenols, anthocyanins, carotenoids, vitamin C, and other phenolic and volatile compounds.

Cancer relevance: Primarily preclinical. Much of the anticancer activity attributed to nasturtium is linked to its conversion of glucotropaeolin to benzyl isothiocyanate. BITC has demonstrated antiproliferative, pro-apoptotic, cell-cycle inhibitory, autophagy-modulating, anti-invasive, and antimetastatic activity across multiple experimental cancer models.

Typical mechanisms: BITC formation ↑; ROS modulation; apoptosis ↑; autophagy modulation; cell-cycle arrest ↑; proliferation ↓; AKT signaling ↓ in selected models; migration/invasion ↓; detoxification and NRF2-associated signaling modulation.

Clinical relevance: Nasturtium herb has been clinically studied primarily in combination with horseradish root for urinary and respiratory tract infections. Randomized trials support activity against recurrent uncomplicated urinary tract infections, although these combination studies cannot attribute the full clinical effect specifically to nasturtium.

Bioavailability: Human studies demonstrate metabolism and systemic exposure to benzyl-isothiocyanate-derived metabolites after consumption of Tropaeolum majus, supporting conversion of plant glucotropaeolin to biologically available BITC-related metabolites.

Processing consideration: Bioactive composition is strongly affected by processing because myrosinase converts glucotropaeolin to BITC. Heat can inactivate myrosinase, whereas crushing or chopping fresh tissue promotes hydrolysis. Commercial extracts may contain substantially different glucotropaeolin and BITC levels depending on processing.

Nasturtium (Tropaeolum majus) — An edible medicinal plant, also called Indian cress or garden nasturtium, whose principal mechanistically relevant phytochemical system is the benzyl glucosinolate glucotropaeolin and its myrosinase-generated hydrolysis product benzyl isothiocyanate (BITC). It is formally classified as a Food Source / medicinal herb / glucosinolate-rich plant. Standard abbreviations include Nast for nasturtium and BITC for its major active isothiocyanate. Leaves, flowers, stems, and seeds are edible, but glucosinolate content and conversion to BITC vary substantially with plant tissue, processing, storage, and myrosinase activity. Most experimental anticancer activity attributed to nasturtium is mechanistically attributable to BITC rather than to intact whole-plant material.

Primary mechanisms (ranked):

  1. Glucotropaeolin hydrolysis by myrosinase generates BITC, the principal reactive isothiocyanate responsible for much of nasturtium's experimentally observed biological activity.
  2. BITC disrupts mitochondrial electron transport, including complex III in established models, increasing mitochondrial ROS and depleting reduced glutathione; this oxidative stress can initiate mitochondrial apoptosis selectively in susceptible cancer cells.
  3. Mitochondrial apoptotic signaling is activated through membrane-potential loss, Bax/Bak activation, cytochrome-associated pathways, caspase activation, PARP cleavage, and in some models AIF/Endo G release.
  4. Cell-cycle progression is inhibited, particularly through G2/M arrest involving altered cyclin B1, CDK1, CDC25C, ERK/JNK/p38 MAPK and related regulatory signaling.
  5. PI3K/AKT and NF-κB survival signaling is suppressed in several cancer models, while stress-associated JNK and p38 signaling is commonly activated.
  6. Autophagy is induced by oxidative stress and can contribute to BITC-mediated cancer-cell death, although its functional role is model-dependent.
  7. EMT, migration, and invasion are suppressed through increased epithelial differentiation markers and reduced vimentin, fibronectin, Snail/Slug, c-Met and related metastatic programs.
  8. Chemosensitization has been demonstrated preclinically, including enhancement of cisplatin cytotoxicity and activity against some drug-resistant cancer models.
  9. Intracellular Ca²⁺ elevation contributes to mitochondrial injury and apoptosis in selected cancer models and is therefore a secondary, model-dependent mechanism.
  10. NRF2-associated antioxidant and phase-II detoxification responses are induced in some non-cancer and hepatic models; this is a secondary and context-dependent response that may protect normal tissue but can potentially oppose sustained oxidative cytotoxicity in some cancer contexts.

Bioavailability / PK relevance: Human intervention studies confirm gastrointestinal conversion and systemic absorption after oral nasturtium. Following ingestion of glucotropaeolin-rich freeze-dried material, BITC-related glutathione, cysteinylglycine, cysteine, and N-acetylcysteine conjugates appear in plasma and urine. BITC-related metabolites can remain detectable in plasma for many hours, while protein conjugates and volatile BITC-related compounds may persist for up to approximately 48 hours. Exposure depends strongly on glucotropaeolin content and active myrosinase; heating can inactivate myrosinase, whereas disruption of fresh tissue promotes glucosinolate hydrolysis. Recent analytical work also indicates that commercial processed extracts may contain very low or highly variable glucotropaeolin and BITC concentrations.

In-vitro vs systemic exposure relevance: Anticancer studies commonly expose cultured cells directly to low-micromolar or higher concentrations of purified BITC. Human consumption of nasturtium clearly produces systemic BITC-derived metabolites, but circulating exposure is dominated by conjugated and protein-bound species and cannot presently be assumed to reproduce continuous free-BITC concentrations used in cell culture. Therefore, direct translation of in-vitro anticancer concentrations to dietary nasturtium exposure is not established.

Clinical evidence status: Cancer: preclinical only; evidence consists primarily of cell culture, xenograft, and other animal studies of purified BITC rather than trials of nasturtium for cancer treatment. Non-cancer: human PK/intervention studies and randomized clinical trials exist. A standardized nasturtium-herb plus horseradish-root medicinal product has undergone randomized controlled and phase III/IV studies for recurrent urinary tract infection and respiratory disease, including a 2026 placebo-controlled phase III trial showing reduced recurrence of uncomplicated cystitis. These combination trials support clinical activity of an isothiocyanate-containing phytomedicine but cannot establish the independent contribution of nasturtium.

Safety / translation: Culinary nasturtium is widely consumed as an edible plant, and clinical combination preparations have generally shown acceptable tolerability in studied populations. However, anticancer doses of purified BITC should not be inferred from culinary exposure: high-dose BITC caused toxicity in early animal antitumor experiments. Reactive isothiocyanates also form glutathione and protein conjugates, making dose, formulation, tissue exposure, and processing important determinants of both efficacy and toxicity.

Nasturtium and BITC Mechanisms

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation
1 Glucotropaeolin to BITC conversion BITC exposure ↑ BITC exposure ↑ P/R Generation of principal reactive bioactive Requires glucotropaeolin plus functional myrosinase; strongly affected by chopping, heating, processing, storage and formulation.
2 Mitochondrial respiratory chain and ROS Complex III ↓; ROS ↑; GSH ↓ ROS ↔ or smaller ↑ (model-dependent) P/R Oxidative stress and mitochondrial injury One of the strongest mechanistically established BITC anticancer pathways; normal mammary and pancreatic epithelial cells showed substantially greater resistance in comparative models.
3 Mitochondrial apoptosis ΔΨm ↓; Bax/Bak ↑; caspases ↑; PARP cleavage ↑ Apoptosis ↔ or smaller ↑ (model-dependent) R/G Programmed cancer-cell death ROS-dependent in multiple models; AIF and Endo G release also occurs in selected prostate cancer cells.
4 Cell-cycle control G2/M arrest ↑; cyclin B1/CDK1/CDC25C ↓ Arrest ↔ or smaller ↑ (model-dependent) G Proliferation ↓ Repeatedly observed across breast, pancreatic, lung and other tumor models.
5 MAPK stress signaling JNK ↑; p38 ↑; ERK variable Activation ↔ or smaller ↑ (model-dependent) R/G Apoptosis and cell-cycle disruption ↑ ERK direction is context-dependent; both activation and inhibition have been reported depending on cancer model and exposure conditions.
6 PI3K AKT survival signaling PI3K ↓; AKT ↓ Variable R/G Survival signaling ↓ Observed in cervical, lung and metabolic cell models; not necessarily universal across tumor types.
7 NF-κB survival signaling NF-κB ↓ (model-dependent) Variable R/G Pro-survival and inflammatory transcription ↓ Especially demonstrated in resistant lung-cancer models; mechanistic importance varies by tumor context.
8 Autophagy Autophagy ↑ Variable R/G Stress response and cancer-cell death ↑ ROS-dependent; can participate in lethal signaling but its exact contribution is model-dependent.
9 EMT migration and invasion E-cadherin ↑; vimentin ↓; Snail/Slug ↓; migration ↓; invasion ↓ Experimental EMT ↓ G Metastatic phenotype ↓ Demonstrated in breast and other cancer models, including xenografts.
10 Chemosensitization Cisplatin response ↑; resistant-cell killing ↑ Not established G Drug sensitivity ↑ Preclinical evidence includes head-and-neck cancer and gefitinib-resistant lung cancer; clinical validation is absent.
11 Intracellular calcium signaling Ca²⁺ ↑ (model-dependent) Not established P/R Mitochondrial stress and apoptosis ↑ Secondary mechanism demonstrated particularly in DU145 prostate cancer cells.
12 NRF2 detoxification response NRF2-associated signaling ↑ (context-dependent) Antioxidant and detoxification genes ↑ G Adaptive electrophile-defense response Secondary mechanism. Potentially protective in normal cells but may counteract sustained ROS-mediated cancer-cell killing in some contexts.
13 Clinical Translation Constraint Effective purified BITC exposure not clinically established Human metabolites demonstrably systemic R/G Translation limited Whole-plant composition, myrosinase activity, processing, conjugation, free BITC exposure and tissue distribution are major variables; no human anticancer efficacy trials establish therapeutic dosing.

P: 0–30 min    R: 30 min–3 hr    G: >3 hr



Scientific Papers found: Click to Expand⟱
9176- BITC,  Nast,    A 14-Day Double-Blind, Randomized, Controlled Crossover Intervention Study with Anti-Bacterial Benzyl Isothiocyanate from Nasturtium (Tropaeolum majus) on Human Gut Microbiome and Host Defense
- Study, UTI, NA
*AntiBio↑, *Dose?, *DEFB1↑, *GutMicro∅, *eff↑,
9213- Nast,  ITCs,    An Epidemiological Study on the Effectiveness of Nasturtium Herb and Horseradish Root (Angocin®Anti-Infekt N) as well as Other Phytopharmaceuticals, Synthetic Products, and Antibiotics on the Course of Acute Upper Respiratory Tract Infection (aURTI)
- Analysis, Inf, NA
*eff↑, *other↝, *Dose↝, *Inf↓, *Bacteria↓, *Inflam↓, *AntiViral↑, *Imm↑, *AntiBio↑,
9214- Nast,    New Contributions to Deepen the Quality-Based Safety Assessment in the Consumption of Edible Nasturtium Flowers-The Role of Volatilome
- Analysis, Nor, NA
*other↝, *Ingr↝, *Ingr↑, *toxicity↝,
9215- Nast,    Clinical evaluation of the efficacy and safety of nasturtium herb and horseradish root versus placebo in the continuous prophylaxis of recurrent uncomplicated cystitis: a double-blind randomised clinical trial
- Trial, UTI, NA
*Inf↓, *Risk↓,
9216- Nast,    A monocentric, randomized, double-blind, controlled crossover trial of nasturtium (Tropaeolum majus) on the lipid regulator prostaglandin E2
- Trial, Nor, NA
*Dose↝, *PGE2∅,

Showing Research Papers: 1 to 5 of 5

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Transcription & Epigenetics(tgid=7) ⓘ

other↝, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

DEFB1↑, 1,   Imm↑, 1,   Inflam↓, 1,   PGE2∅, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

Dose?, 1,   Dose↝, 2,   eff↑, 2,  

Functional Outcomes(tgid=23) ⓘ

Risk↓, 1,   toxicity↝, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 2,   AntiViral↑, 1,   Bacteria↓, 1,   GutMicro∅, 1,   Inf↓, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 1,   Ingr↝, 1,  
Total Targets: 17

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:532  Target#:%  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page